ChemoCentryx
CCXI
#3654
Rank
C$5.34 B
Marketcap
C$74.34
Share price
0.00%
Change (1 day)
36.09%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): C-$2.40

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is C-$2.70. In 2021 the company made an earnings per share (EPS) of C-$2.70 a decrease over its 2020 EPS that were of C-$1.16.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)C-$2.40-11.23%
2021C-$2.70133.33%
2020C-$1.16-16.49%
2019C-$1.3927.63%
2018C-$1.09-305.41%
2017C$0.53-142.53%
2016C-$1.24-19.44%
2015C-$1.54-0%
2014C-$1.5413.68%
2013C-$1.36-16.67%
2012C-$1.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.55-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.37-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.85-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$3.37-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.46-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.11-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.64-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel